Biocon Limited (BOM:532523)
366.00
+3.65 (1.01%)
At close: Nov 20, 2026
Biocon Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Biocon stock has a consensus rating of "Buy" and an average price target of ₹411.84. The average 1-year stock price forecast is 12.52% higher than the current stock price, while the lowest is ₹326.00 (-10.93%) and the highest is ₹490.00 (+33.88%).
Price Target: ₹411.84 (+12.52%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Biocon stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 8 | 8 | 8 | 9 |
| Buy | 3 | 1 | 1 | 1 | 2 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 5 | 5 | 5 | 5 | 4 | 3 |
| Strong Sell | 1 | 1 | 2 | 1 | 1 | 1 |
| Total | 20 | 19 | 19 | 18 | 18 | 18 |
Financial Forecast
Revenue This Year
191.94B
from 169.27B
Increased by 13.39%
Revenue Next Year
219.41B
from 191.94B
Increased by 14.31%
EPS This Year
5.74
from 5.25
Increased by 9.40%
EPS Next Year
9.53
from 5.74
Increased by 66.09%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.